Pancreatic Cancer Research

ResearcherNational Institutes for Quantum Science and TechnologyActive in the last 2 years

Takashi Imai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9049-8102; OpenAlex author ID A5029489298. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Prognostic Significance of Plasma Soluble IL-6 Receptor in Carbon-ion Radiotherapy for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.17406↗
  2. Carbon-ion radiation enhances migration ability and invasiveness of the pancreatic cancer cell, PANC-1, in vitro. Last author DOI 10.1111/j.1349-7006.2011.02190.x↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tsuguhide Takeshima · 1 shared paper, 2025 · strength 0.28
  2. Tetsuro Isozaki · 1 shared paper, 2025 · strength 0.28
  3. Makoto Shinoto · 1 shared paper, 2025 · strength 0.28
  4. Sumitaka Hasegawa · 1 shared paper, 2025 · strength 0.28
  5. Kazutaka Doi · 1 shared paper, 2025 · strength 0.28
  6. Mayumi Fujita · 1 shared paper, 2012 · strength 0.04
  7. Shigeru Yamada · 1 shared paper, 2012 · strength 0.04
  8. Satoshi Endo · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.